Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients

• Published in: BMC cancer 2021-05, Vol.21 (1), p.1-645, Article 645
• Main Authors: Wang, Ding, Wei, Guodong, Ma, Ju, Cheng, Shuai, Jia, Longyuan, Song, Xinyue, Zhang, Ming, Ju, Mingyi, Wang, Lin, Zhao, Lin, Xin, Shijie
• Format: Article
• Language: English
• Subjects: Apoptosis; Breast cancer; Cancer therapies; Care and treatment; Cell death; Chemotherapy; Dehydrogenases; Dendritic cells; Development and progression; Estrogens; Ferroptosis; Gene expression; Gene set enrichment analysis; Genetic aspects; Genomes; Glucosephosphate dehydrogenase; Health aspects; Immune status; Immunotherapy; Interferon; Kinases; Lymphocytes T; Medical prognosis; Morbidity; Principal components analysis; Prognosis; Prognostic signature; Proteins; Regression analysis; Risk groups; Sulfur; Survival analysis
• ISSN: 1471-2407; 1471-2407
• DOI: 10.1186/s12885-021-08341-2

Background Breast cancer (BRCA) is a malignant tumor with high morbidity and mortality, which is a threat to women's health worldwide. Ferroptosis is closely related to the occurrence and development of breast cancer. Here, we aimed to establish a ferroptosis-related prognostic gene signature for predicting patients' survival. Methods Gene expression profile and corresponding clinical information of patients from The Cancer Genome Atlas (TCGA) database and Gene Expression Omnibus (GEO) database. The Least absolute shrinkage and selection operator (LASSO)-penalized Cox regression analysis model was utilized to construct a multigene signature. The Kaplan-Meier (K-M) and Receiver Operating Characteristic (ROC) curves were plotted to validate the predictive effect of the prognostic signature. Gene Ontology (GO) and Kyoto Encyclopedia of Genes, Genomes (KEGG) pathway and single-sample gene set enrichment analysis (ssGSEA) were performed for patients between the high-risk and low-risk groups divided by the median value of risk score. Results We constructed a prognostic signature consisted of nine ferroptosis-related genes (ALOX15, CISD1, CS, GCLC, GPX4, SLC7A11, EMC2, G6PD and ACSF2). The Kaplan-Meier curves validated the fine predictive accuracy of the prognostic signature (p < 0.001). The area under the curve (AUC) of the ROC curves manifested that the ferroptosis-related signature had moderate predictive power. GO and KEGG functional analysis revealed that immune-related responses were largely enriched, and immune cells, including activated dendritic cells (aDCs), dendritic cells (DCs), T-helper 1 (Th1), were higher in high-risk groups (p < 0.001). Oppositely, type I IFN response and type II IFN response were lower in high-risk groups (p < 0.001). Conclusion Our study indicated that the ferroptosis-related prognostic signature gene could serve as a novel biomarker for predicting breast cancer patients' prognosis. Furthermore, we found that immunotherapy might play a vital role in therapeutic schedule based on the level and difference of immune-related cells and pathways in different risk groups for breast cancer patients. Keywords: Breast cancer, Ferroptosis, Prognostic signature, Immune status